DYN — Dynegy
Unknown Industry · Unknown Sector
Key Facts
| Status | Active |
| Sector | Unknown Sector |
| Industry | Unknown Industry |
| Joined | 2000-10-02 |
| Tenure | 9 yrs |
Dyne Therapeutics Inc. is a clinical-stage neuromuscular disease company focused on discovering and advancing life-altering therapies for people living with genetically-driven neuromuscular diseases. The company's FORCE platform develops targeted therapies designed to overcome limitations of delivery to muscle tissue and the central nervous system (CNS). The company's FORCE platform therapies consist of a payload rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment attached to the payload using the linker. The company's pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Industry Peers
—
Sector Peers
—
S&P 500 Timeline
2000-10-02Joined S&P 500
2009-12-18Removed from S&P 500
Data source:
Wikipedia · CC BY-SA 4.0 · Updated 2026-07-10